Need to revisit heart failure treatment guidelines for hyperkalaemia management during the use of mineralocorticoid receptor antagonists

Eur J Heart Fail. 2018 Sep;20(9):1247-1251. doi: 10.1002/ejhf.1217. Epub 2018 Jun 8.
No abstract available

Publication types

  • Review

MeSH terms

  • Disease Management*
  • Heart Failure* / complications
  • Heart Failure* / drug therapy
  • Heart Failure* / physiopathology
  • Humans
  • Hyperkalemia* / blood
  • Hyperkalemia* / drug therapy
  • Hyperkalemia* / etiology
  • Mineralocorticoid Receptor Antagonists / pharmacology*
  • Potassium / blood*
  • Practice Guidelines as Topic*
  • Stroke Volume / physiology*

Substances

  • Mineralocorticoid Receptor Antagonists
  • Potassium